The Clinical Outcome of Patients with B-cell Lymphoproliferative Disease (B-LPD) Seems to Be Improved by the Success in Induction of Polymerase Chain Reaction (PCR) Negativity Achieved by High Dose Therapy with Autologous Stem Cell Transplantation

Abstract

The comparison of clinical outcome of patients with B-cell lymphoproliferative disease according to their PCR status after the high dose therapy with autologous stem cell transplantation or rituximab therapy.